In patients with overweight and obesity, the benefits of even small amounts of weight loss may extend far beyond all that is measurable. Our featur......READ MORE
by Caroline M. Apovian, MD, FACP, FTOS, DABOM, Louis J. Aronne, MD, Judith Korner, MD, PhD
In patients with overweight or obesity, the urgency to intervene is increased in those who are experiencing current or imminent health risks from t......READ MORE
by Caroline M. Apovian, MD, FACP, FTOS, DABOM, Louis J. Aronne, MD, Judith Korner, MD, PhD
Numerous biological mechanisms, along with hormonal and neural interactions, undermine a patient’s efforts to maintain weight loss. Our featured ex......READ MORE
by Caroline M. Apovian, MD, FACP, FTOS, DABOM, George A. Bray, MD, F. Xavier Pi-Sunyer, MD
The differential variability of percentage weight loss seen in clinical practices and lack of statistically significant weight- loss results report......READ MORE
by Caroline M. Apovian, MD, FACP, FTOS, DABOM, George A. Bray, MD, Xavier Pi-Sunyer, MD
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have multiple effects, including glycemic control through suppressing pancreatic glucagon sec......READ MORE
by Caroline M. Apovian, MD, FACP, FTOS, DABOM, George A. Bray, MD, F. Xavier Pi-Sunyer, MD
For motivated patients with a body mass index (BMI) of ≥30 kg/m2 or ≥27 kg/m2 with comorbidities, treatment guidelines recommend that US Food and D......READ MORE
